Most Read Articles
Roshini Claire Anthony, 04 Apr 2019

In addition to an intensive weight loss programme, the use of continuous positive airway pressure (CPAP) could improve absolute weight loss in individuals with obesity and obstructive sleep apnoea (OSA), according to a study presented at ENDO 2019.

4 days ago
The ketogenic and Modified Atkin’s diets are effective treatments for children with refractory epilepsy of genetic aetiology, a new study suggests.
5 days ago
Extremely premature neonates who have been exposed to pre-eclampsia in utero are at high risk of developing severe respiratory distress syndrome and severe bronchopulmonary dysplasia, according to a study.
Pearl Toh, 4 days ago
A contraceptive vaginal system (Annovera) releasing a combination of segesterone acetate and ethinyl estradiol (SA/EE) effectively inhibits ovulation up to a year even at low systemic levels of SA, reports a review study presented at ENDO 2019.

REVEAL score best predictor of mortality in patients with pulmonary arterial hypertension

09 Feb 2019

Survival rates for pulmonary arterial hypertension (PAH) in this REVEAL* study from a Southeast Asian population are similar with those from other national registries. Moreover, this study validates the REVEAL score as a good predictor of mortality.

A total of 148 patients were included (mean age 50.8±15.9 years; 77 percent female). Racial distribution was consistent with the population census.

Congenital heart disease-associated PAH (35.8 percent), idiopathic PAH (29.7 percent) and connective tissue disease-associated PAH (24.3 percent) were the most common aetiologies. Nearly half of the patients presented with World Health Organization Functional Class (FC) II (48.6 percent), followed by FC III (28.8 percent).

More than half of the patients (54.1 percent) were taking phosphodiesterase type 5 (PDE5) inhibitor monotherapy. Survival rate at the end of the first year was 85.8 percent, while those at 3, 5, 7 and 10 years were 70.9 percent, 66.9 percent, 61.5 percent and 55.4 percent, respectively.

The REVEAL score was the best predictor of mortality, with a score >6 identified as a cutoff. Other predictors were as follows: mean right atrial pressure, heart rate, aetiology, age and N-terminal probrain natriuretic peptide.

In this study, the authors enrolled patients with PAH referred to a pulmonary hypertension specialty centre from January 2003 to December 2016. They also analysed baseline characteristics and survival. A multilevel structural equation model was applied based on a forward predictor selection procedure to identify predictors associated with mortality.

“PAH is a rare and fatal disease. Data from Asia are lacking compared with the West,” the authors noted.

*Registry to Evaluate Early And Long‐term PAH Disease Management

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 04 Apr 2019

In addition to an intensive weight loss programme, the use of continuous positive airway pressure (CPAP) could improve absolute weight loss in individuals with obesity and obstructive sleep apnoea (OSA), according to a study presented at ENDO 2019.

4 days ago
The ketogenic and Modified Atkin’s diets are effective treatments for children with refractory epilepsy of genetic aetiology, a new study suggests.
5 days ago
Extremely premature neonates who have been exposed to pre-eclampsia in utero are at high risk of developing severe respiratory distress syndrome and severe bronchopulmonary dysplasia, according to a study.
Pearl Toh, 4 days ago
A contraceptive vaginal system (Annovera) releasing a combination of segesterone acetate and ethinyl estradiol (SA/EE) effectively inhibits ovulation up to a year even at low systemic levels of SA, reports a review study presented at ENDO 2019.